Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Sialorrhea is a frequently occurring problem with detrimental effect on quality of life in
25% of PD patients. Currently, there is no intervention approved for sialorrhea in Parkinsons
and evidence is only available for a 30-day effect or less. We hypothesize that
glycopyrrolate will have a lasting effect in the reduction of sialorrhea in PD patients.